Instil Bio, Inc.
TIL
$7.96
-$0.02-0.25%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -41.28% | -41.58% | -44.94% | -42.49% | -26.68% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -58.44% | -16.69% | 33.30% | -5.33% | -26.42% |
| Operating Income | 58.44% | 16.69% | -33.30% | 5.33% | 26.42% |
| Income Before Tax | 85.09% | 31.14% | 40.98% | -43.42% | -16.04% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 85.09% | 31.14% | 40.98% | -43.42% | -16.04% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 85.09% | 31.14% | 40.98% | -43.42% | -16.04% |
| EBIT | 58.44% | 16.69% | -33.30% | 5.33% | 26.42% |
| EBITDA | 57.04% | 11.05% | -44.77% | -1.87% | 25.18% |
| EPS Basic | 85.64% | 33.74% | 43.17% | -41.40% | -15.53% |
| Normalized Basic EPS | 61.59% | 31.74% | -22.73% | 25.73% | 39.76% |
| EPS Diluted | 85.64% | 33.74% | 43.17% | -41.40% | -15.53% |
| Normalized Diluted EPS | 61.59% | 31.74% | -22.73% | 25.73% | 39.76% |
| Average Basic Shares Outstanding | 3.82% | 3.92% | 3.86% | 1.43% | 0.44% |
| Average Diluted Shares Outstanding | 3.82% | 3.92% | 3.86% | 1.43% | 0.44% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |